Document is current
Any future updates will be listed below
-
Authors
Andersen, Andreas
Bagger, Jonatan I.
Sørensen, Samuel K.
Baldassarre, Maria P. A.
Pedersen-Bjergaard, Ulrik
Forman, Julie L.
Gislason, Gunnar
Lindhardt, Tommi B.
Knop, Filip K.
Vilsbøll, Tina https://orcid.org/0000-0002-0456-6787
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03150030 at ClinicalTrials.govDocuments that mention this clinical trial
Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study
https://doi.org/10.1186/s12933-021-01425-0
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF 16230)
Region Hovedstaden (E-19280-51-07)
- License Information
-
More Information
Article History
Received: 21 September 2021
Accepted: 3 December 2021
First Online: 24 December 2021
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Scientific Ethical Committee of the Capital Region of Denmark (ID No. H-16046212) and the Danish Data Protection Agency (ID No. HGH-2017-030). An oral and written consent was obtained from all participants prior to inclusion in the study.
: All authors approved the manuscript for publication.
: AA, MPAB, SKS, TBL and GG declare no conflicts of interest. JIB has received lecture fee from Novo Nordisk. UPB has served on advisory boards for AstraZeneca/Bristol Myers Squibb, Sanofi Aventis, Novo Nordisk and Zealand Pharma and has received lecture fee and research grant from Novo Nordisk. FKK has served on scientific advisory panels and/or been part of speaker’s bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma. TV has served on scientific advisory panels, been part of speaker’s bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gilead, GSK, Mundipharma, MSD/Merck, Novo Nordisk, Sanofi and Sun Pharmaceuticals.
